← Back to Search

Dynamic Stability Exercises for Thumb Arthritis

Phase 2
Recruiting
Led By Corey McGee
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
adults with radiographically-confirmed thumb CMC OA
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial will help determine if a novel exercise regimen reduces radiographic thumb CMC joint misalignment among persons with thumb carpometacarpal osteoarthritis.

Who is the study for?
This trial is for adults with confirmed thumb CMC osteoarthritis who haven't had hand rehab in the last 6 months. It's not for those with severe arthritis, recent cortisone treatments, joint replacements, inflammatory arthritis, or conditions like Marfan's or Ehlers Danlos Syndrome.Check my eligibility
What is being tested?
The study tests a dynamic stability exercise program against standard care to see if it improves thumb alignment and function in people with thumb CMC OA. Participants will have CAT scans before and after an 8-week exercise program to measure changes.See study design
What are the potential side effects?
Since this trial involves physical exercises rather than medication, side effects may include muscle soreness or strain. However, these are typically mild and temporary as the body adjusts to new activities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with thumb arthritis through imaging tests.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 weeks post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 weeks post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Subluxation of thumb carpometacarpal joint as per CAT scan
Sonography, Speech

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dynamic Stability Exercise ProgramExperimental Treatment1 Intervention
Involves four 60-minute occupational therapy visits as well as a daily home program across a 8-week period. Clinic visits focus primarily on home program coaching, and progression of the exercise regimen. Home programs involve daily exercises which follow the intensity and duration recommended for older adults. The intervention focuses on enhancing mobility and strength of the thumb for use during daily activities.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for thumb osteoarthritis include joint protection techniques, splinting, and specialized exercise programs like the Dynamic Stability (DS) Exercise Program. The DS Exercise Program aims to improve joint mechanics and stability by strengthening the muscles around the thumb carpometacarpal (CMC) joint, thereby reducing joint misalignment and pain. This is achieved through targeted exercises that enhance the dynamic stability of the joint, which can help in maintaining proper joint function and reducing the progression of OA. For patients, this means potentially less pain, improved hand function, and a better quality of life.

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,391 Previous Clinical Trials
1,553,095 Total Patients Enrolled
Corey McGeePrincipal InvestigatorUMN

Media Library

Dynamic Stability Exercise Program Clinical Trial Eligibility Overview. Trial Name: NCT05247398 — Phase 2
Thumb Osteoarthritis Research Study Groups: Dynamic Stability Exercise Program
Thumb Osteoarthritis Clinical Trial 2023: Dynamic Stability Exercise Program Highlights & Side Effects. Trial Name: NCT05247398 — Phase 2
Dynamic Stability Exercise Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05247398 — Phase 2
~0 spots leftby Jun 2024